Lineage Cell Therapeutics, Inc.
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2016 | $12.1M | $142.6M | $22.1M |
| FY2017 | $9.0M | $173.2M | $36.8M |
| FY2018 | $9.4M | $101.7M | $23.6M |
| FY2019 | $14.2M | $125.5M | $9.5M |
| FY2020 | $12.8M | $107.9M | $32.6M |
| FY2021 | $83.6M | $174.5M | $55.7M |
| FY2022 | $51.7M | $123.7M | $11.4M |
| FY2023 | $39.0M | $101.0M | $35.4M |
| FY2024 | $36.2M | $113.2M | $45.8M |
| FY2025 | $69.2M | $112.6M | $40.8M |